The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future ...
Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...
Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...
1d
GlobalData on MSNTC BioPharm completes dosing in Cohort A of Phase IIb trial for AMLThe trial was designed to evaluate the therapy’s efficacy and safety in treating AML, as well as myelodysplastic syndromes.
Vistagen Therapeutics' Q3 2025 earnings reveal progress on Phase 3 trials for social anxiety drug fasedienol, innovative therapies, and strong ...
Clinical trials have been pivotal to the improvements in public health and clinical care, leading to many millions of ...
Cancer researcher Karen Sfanos says she is 'terrified' of the impact of cuts to NIH funding that supports vital biomedical ...
Finding a clinical trial that is a good fit can be challenging. Here's how to get the most out of your clinical trial search.
GenSight Biologics announces efficacy and safety results for Lumevoq gene therapy at the conclusion of the REFLECT phase III clinical study: Paris Thursday, February 13, 2025, 17: ...
Biogen and Eisai have spent much of Leqembi’s launch convincing physicians and patients that it’s safe to treat Alzheimer’s ...
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results